PTEN and melanoma: Similar to other types of solid tumors, melanoma shows frequent alterations in MAPK and PI3K/PTEN signaling pathways, especially with 40–60% of cultured primary melanoma cells bearing activating BRAF mutations (12–20) (Figure 2).